KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Equity Average (2016 - 2025)

Astrana Health (ASTH) has disclosed Equity Average for 15 consecutive years, with $777.4 million as the latest value for Q4 2025.

  • Quarterly Equity Average rose 9.32% to $777.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $777.4 million through Dec 2025, up 9.32% year-over-year, with the annual reading at $746.0 million for FY2025, 12.23% up from the prior year.
  • Equity Average hit $777.4 million in Q4 2025 for Astrana Health, up from $773.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $777.4 million in Q4 2025 to a low of $338.3 million in Q1 2021.
  • Historically, Equity Average has averaged $579.3 million across 5 years, with a median of $572.1 million in 2023.
  • Biggest five-year swings in Equity Average: soared 90.87% in 2021 and later grew 9.32% in 2025.
  • Year by year, Equity Average stood at $444.7 million in 2021, then increased by 17.92% to $524.3 million in 2022, then grew by 15.8% to $607.2 million in 2023, then grew by 17.13% to $711.2 million in 2024, then increased by 9.32% to $777.4 million in 2025.
  • Business Quant data shows Equity Average for ASTH at $777.4 million in Q4 2025, $773.5 million in Q3 2025, and $761.0 million in Q2 2025.